EDGAR Filing Documents for 0001517126-13-000369

Form 8-K - Current report:

SEC Accession No. 0001517126-13-000369

Filing Date

2013-12-20

Accepted

2013-12-20 14:57:32

Documents

Period of Report

2013-11-08

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	form8k.htm	8-K	54940
2	EXHIBIT 99.1	exhibit991.htm	EX-99.1	171319
3	EXHIBIT 99.2	exhibit992.htm	EX-99.2	43283
4	EXHIBIT 10.1	exhibit101.htm	EX-10.1	45318
5	EXHIBIT 10.2	exhibit102.htm	EX-10.2	56139
6	EXHIBIT 10.3	exhibit103.htm	EX-10.3	57626
7	EXHIBIT 10.4	exhibit104.htm	EX-10.4	59082
8	EXHIBIT 10.5	exhibit105.htm	EX-10.5	57532
9	IMAGE	f991image.jpg	GRAPHIC	75069
	Complete submission text file	0001517126-13-000369.txt		650486

Mailing Address 9107 WILSHIRE BLVD., SUITE 450 BEVERLY HILLS CA 90210

Business Address 9107 WILSHIRE BLVD., SUITE 450 BEVERLY HILLS CA 90210 1-888-267-1175

PHARMA INVESTING NEWS, INC. (Filer) CIK: 0001520047 (see all company filings)